thousands of women whose breast cancer has become resistant to standard treatment could benefit from a new drug combination , claim researchers . it is hoped the new approach will target cancer stem cells that evade conventional drugs and cause the tumour to re-grow . thousands of women whose breast cancer has become resistant to standard treatment could benefit from a new drug combination .